BuckleyRM, BraffmanMN, SternJJ. Opportunistic infections in the acquired immunodeficiency syndrome. Semin Oncol1990; 17: 335— 49.
2.
SchneiderMME, HoepelmanAIM, SchattenkerkJKME, NielsenTL, van derGraaf Y, FrissenJPHJ, A controlled trial of aerosolized pentamidine or trimethoprim—sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med1992; 327: 1836— 41.
3.
PodzamczerD, SantinM, JimenezJ, CasanovaA, BolaoF, GudiolGRF. Thrice-weekly cotrimoxazole is better than weekly dapsone—pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS1993; 7: 501— 6.
4.
HardyWD, FeinbergJ, FinkelsteinDM, PowerME, HeW, KaczkaC. A controlled trial of trimethoprim—sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med1992; 327: 1842— 8.
5.
SattlerFR, CowanR, NielsenDM, RuskinJ.Trimethoprim—sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann Intern Med1988; 109: 280— 7.
6.
WhartonJM, ColemanDL, WofsyCB, LuceJM, BlumenfeldW, HadleyWK. Trimethoprim—sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med1986; 105: 37— 44.
7.
MedinaI, MillsJ, LeoungG, HopewellPC, LeeB, ModinG. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim—sulfamethoxazole versus trimethoprim—dapsone. N Engl J Med1990; 323: 776— 82.
8.
StraussKW. Endocrine complications of the acquired immunodeficiency syndrome. Arch Intern Med1991; 151: 1441— 4.
9.
GrinspoonSK. BilezikianJP. HIV disease and the endocrine system. N Engl J Med1992; 327: 1360— 5.
10.
JickH.Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis1982; 4: 426— 8.
JaffeHS, AbramsDI, AmmannAJ, LewisBJ, GoldenJA. Complications of cotrimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet1983; 2: 1109— 11.
13.
GordinFM, SimonGL, WofsyCB, MillsJ.Adverse reactions to trimethoprim—sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med1984; 100: 495— 9.
14.
LeoungGS, MillsJ, HopewellPC, HughesW, WofsyC.Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med1986; 105: 45— 8.
15.
LeeBL, MedinaI, BenowitzNL, JacobP, WofsyCB, MillsJV. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome (AIDS): evidence of drug interactions. Ann Intern Med1989; 110: 606— 11.
16.
MillsJ, LeoungG, MedinaI, HopewellPC, HughesWT, WofsyC.Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Antimicrob Agents Chemother1988; 32: 1057— 60.
17.
ChoiMJ, FernandezPC, PatnaikA, Coupaye-GerardB, D'andreaD, SzerlipH. Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med1993; 328: 703— 6.
